mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.003 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.004 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
0.004 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.006 |